Recent research reported that a dose of 50 mg/kg of diosmin orally administered for 6 weeks significantly reduced cognitive dysfunction and hippocampal neuronal loss and apoptosis, potentially by upregulating the PI3K/AKT pathway in AD rats in a dose-dependent manner [88]. The gene discussed is AKT1; the disease is Alzheimer disease.